YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)
Parker Waichman Alonso LLP Headlines by Topic
Vioxx
Merck’s Vioxx Payouts to Begin in August
Jan 1, 2008 | Parker Waichman Alonso LLP
New Jersey-based Merck & Company will begin funding $4.85 billion to resolve state and federal claims over its painkiller Vioxx. The first...
Vioxx Settlement All-or-Nothing Provision Prompts Some Lawyers to Seek Changes
Dec 21, 2007 | Parker Waichman Alonso LLP
The Vioxx settlement announced with great fanfare last month has not satisfied all Vioxx victims, and now their lawyers are asking a judge to change...
Vioxx Lawsuit Settlement Could Rank Among the Largest Defective Drug Settlements
Nov 12, 2007 | Parker Waichman Alonso LLP
Merck’s proposed Vioxx settlement could become on of the largest defective drug lawsuit settlements in history if it is accepted by a majority...
Vioxx Victims to Share $4.85 Billion under Settlement Agreement with Merck
Nov 9, 2007 | Parker Waichman Alonso LLP
Vioxx maker Merck will spend $4.85 billion to settle a significant number of lawsuits filed against it for injuries caused by the painkiller. ...
Vioxx Lawsuit Asks that Merck Pay for Medical Monitoring
Oct 26, 2007 | Parker Waichman Alonso LLP
Vioxx users, anxious that they could have unknowingly suffered health consequences from using the defective drug, have taken Vioxx maker Merck to...
FDA Must Produce Vioxx Documents
Oct 17, 2007 | Parker Waichman Alonso LLP
Vioxx documents requested by an attorney must be turned over by the Food & Drug Administration (FDA), a US District Court Judge has ruled. ...
Vioxx Maker Merck Sued by New York For Medicaid Fraud
Sep 19, 2007 | Parker Waichman Alonso, LLP
Vioxx, a defective drug pulled off the market in 2004, is the target of yet another lawsuit. Earlier this week, the state of New York joined...
Possible Cause of Vioxx Heart Attack Risk Discovered
Aug 27, 2007 | Parker Waichman Alonso, LLP
Vioxx and other cox-2 inhibitors increase the production of a protein that encourages blood clotting, concludes a study published in The Journal of...
FDA Approving Fewer New Drugs in Wake of Vioxx, Avandia, Other Scandals
Aug 23, 2007 | Parker Waichman Alonso, LLP
The Food & Drug Administration (FDA) is still struggling to regain credibility after its approval process came under fire as a result of scandals...
Eli Lilly Settles Zyprexa Lawsuits; Attempts to Shift Blame to Legal Advertising
Jun 19, 2007 | Parker Waichman Alonso LLP
Eli Lilly, the makers of Zyprexa announced it had settled another 900 lawsuits against its anti-psychotic medication Zyprexa, on that very same day...
Page 5/35 [first] [prev] 1 2 3 4 5 6 7 8 9 10 ... [next] [last]
Vioxx
